G49-39054-97542
2 vaccinations
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 038 / NH
- Registered
- 2021-05-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-05-04
Dose 2 — Pfizer-BioNTech
-
2021-05-18
Registered in v-safe
-
2021-05-18
Survey response — day 14, dose 2MedDRA: Asthenia, Dizziness, Fatigue, Heavy menstrual bleeding, Menstruation irregular, Nausea, Pain in extremity, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Dizziness and resulting nausea for 12 days, fatigue and weakness for 12 days, irregular very heavy period for 8 days, fever for one day, sore arm for one dayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
-
2021-06-03
Survey response — day 28, dose 2MedDRA: Heavy menstrual bleeding, Hypomenorrhoea, Menstruation irregular — Feeling: GoodFree text: Menstrual period went back on schedule but was extremely light, this one after the extra menstrual period begun 2 days after the second vaccine dose. As already reported, the extra period at vaccine tome was extremely heavy and long in duration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-08
- 2021-06-15
- 2021-08-03
- 2021-11-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-05-04 | Pfizer-BioNTech |
Free text
Release 8 — day 14, dose 2
Symptoms: Dizziness and resulting nausea for 12 days, fatigue and weakness for 12 days, irregular very heavy period for 8 days, fever for one day, sore arm for one day
Release 8 — day 28, dose 2
Symptoms: Menstrual period went back on schedule but was extremely light, this one after the extra menstrual period begun 2 days after the second vaccine dose. As already reported, the extra period at vaccine tome was extremely heavy and long in duration.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Hypomenorrhoea | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release